11/14/2006 | BT | Corautus ends quarter with $19.7 million, still considering possible strategic alternatives
|
8/10/2006 | BT | Corautus continues work on Genasis severe angina trial, says cash will fund operations through Q3 2007
|
7/13/2006 | BT | Corautus: FDA lifts clinical hold on Genasis phase 2b trial for treatment of severe angina
|
7/6/2006 | BT | Corautus converts debt held by Boston Scientific into equity
|
5/31/2006 | BT | Corautus Genetics responds to FDA clinical hold of VEGF-2 angina study
|
5/26/2006 | BT | Nasdaq notifies Corautus of non-compliance due to low stock price
|
5/15/2006 | BT | Corautus reports halted Genasis trial could still provide valuable information
|
4/10/2006 | BT | Corautus ends enrollment in previously suspended Genasis severe angina trial on advice of monitoring committee
|
3/20/2006 | BT | Corautus reports fourth-quarter, year-end loss for 2005, suspends Genasis trial
|
3/15/2006 | BT | Market Commentary: Cell Genesys rises then ends off; Critical Therapeutics loses 2%; Siga up 10%; Corautus rebounds
|
3/14/2006 | BT | Corautus stops trial of VEGF-2 for treatment of angina, cancels follow-on offering
|
3/14/2006 | BT | Market Commentary: PharmAthene going public via Siga merger; Corautus crashes, deal nixed; Novavax, Generex up
|
3/10/2006 | BT | New Issue: Corautus raises $29 million in upsized follow-on of 7.5 million shares at $3.85 each
|
3/10/2006 | BT | Market Commentary: Insmed, Corautus off on deals; NPS Pharma gains, dives on FDA; CV Therapeutics higher; Kos up
|
2/24/2006 | BT | Corautus plans follow-on offering of 6.5 million shares via Lazard
|
2/24/2006 | BT | Market Commentary: Corautus, Cepheid deals emerge; BioMarin bounces; GCP gains on PIPEs deal; Par pounced on news
|
2/23/2006 | BT | Corautus Genetics to complete Genasis trial enrollment later than planned
|
2/6/2006 | BT | Corautus updates agreements for VEGF-2 product testing, distribution
|
1/26/2006 | BT | Corautus Genetics continues phase 2b study of VEGF-2 for severe angina
|
1/12/2006 | BT | Corautus Genetics files $50 million stock, warrants shelf
|
1/11/2006 | BT | Corautus signs agreement with Boston hospital for tests of VEGF-2
|
11/3/2005 | BT | Corautus Genetics receives FDA fast track designation for VEGF-2
|
6/28/2005 | PP | Market Commentary: Commonwealth Bankshares wraps $19.34 million deal; volume picks up as stocks improve
|
6/28/2005 | BTPP | New Issue: Corautus wraps $17.86 million private placement of stock
|